Five Things to Know About Medicare Site-Neutral Payment Reforms
This brief examines key facts around proposals to align Medicare payments for outpatient services across care settings, otherwise known as “site-neutral payment reforms.”
View the Latest: Prices
Filter
-
-
Challenges with Effective Price Transparency Analyses
Issue BriefPromoting price transparency in health care is a policy approach with bi-partisan support in Congress and the public at large. This analysis examines the vast troves of price transparency data that payers are required and finds unlikely prices, inconsistencies, and other oddities that pose major challenges for efforts to use it to promote competition and drive down prices.
-
Few Consumers Use Information on Health Provider Quality or Price
From Drew AltmanIn this column for The Wall Street Journal's Think Tank, Drew Altman discusses new poll findings showing very small numbers of consumers are using provider quality and price information.
-
What are the recent and forecasted trends in prescription drug spending?
FeatureThis slideshow looks at past, present and future trends in prescription drug spending with a focus on the role of specialty drugs.
-
Health of the Healthcare System: An Overview
FeatureThis slideshow accompanies the video, “Health of the Healthcare System,” a diagnostic look at the state of the U.S. healthcare system. It compares the United States to other countries in four key areas: health, quality of health care, cost of care, and accessibility.
-
Prescription Drugs’ Sizable Share of Health Spending
News ReleaseIn his latest column for The Wall Street Journal‘s Think Tank, Drew Altman explains why prescription drug spending may be a larger share of health spending than most people think, depending on how you look at it. All previous columns by Drew Altman are online.
-
How High Drug Prices Weigh on the Sickest Americans
From Drew AltmanIn this column for The Wall Street Journal's Think Tank, Drew Altman explores the data behind public concern about prescription drug costs and highlights that the people most in need are the most burdened by the problem.
-
High Health-Care Prices: More Talk Than Action
From Drew AltmanIn this column for The Wall Street Journal's Think Tank, Drew Altman explores how price is the major factor that distinguishes the cost of our health care system from those in other developed nations, yet most efforts in the U.S. to address health-care costs don’t focus on price much at all.
-
Why Data on Health-Care Price Variation Doesn’t Itself Solve the Problem
News ReleaseIn his latest column for The Wall Street Journal's Think Tank, Drew Altman discusses a new Blue Cross Blue Shield Association report on “extreme price variation” in health care services and the limits of consumer information as a solution to the problem. All previous columns by Drew Altman are available online.
-
Health Spending Is Rising More Sharply Again
From Drew AltmanIn this column for The Wall Street Journal's Think Tank, Drew Altman discusses why high health care prices are a problem for consumers but not a cause of renewed growth in health spending.